Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia: A Case-Control Study

Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system

(2012) Cuie Guang et al.   Archives of Cardiovascular Diseases

Factor XI is a substrate for oxidoreductases: Enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis

(2012) Bill Giannakopoulos et al.   JOURNAL OF AUTOIMMUNITY

Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008

(2012) Reeta Lamminpää et al.   BMC Pregnancy and Childbirth

Evaluation and management of severe preeclampsia before 34 weeks' gestation

(2011) Baha M. Sibai   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I

(2011) Yiannis Ioannou et al.   ARTHRITIS AND RHEUMATISM

Beta 2 glycoprotein I is a substrate of thiol oxidoreductases

(2010) F. H. Passam et al.   BLOOD

Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1

(2010) F. H. PASSAM et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

On stress and pressure

(2010) Curt D. Sigmund   NATURE

A redox switch in angiotensinogen modulates angiotensin release

(2010) Aiwu Zhou et al.   NATURE

Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension

(2010) James M. Roberts et al.   NEW ENGLAND JOURNAL OF MEDICINE

World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries

(2009) J Villar et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY